Risk-benefit analysis for drotrecogin alfa (activated)

Roland M.H. Schein, Gary T. Kinasewitz

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Risk-benefit analysis for drotrecogin alfa (activated)'. Together they form a unique fingerprint.

Medicine & Life Sciences